Replimune Group, Inc. (REPL) analyst actions
Rating and price-target actions on REPL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the REPL overview →
3 measured REPL analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Replimune Group Inc. (REPL) And Encourages Shareholders to Reach Out | Press release | +0.60% | +1.06% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Replimune Group, Inc. (REPL) And Encourages Shareholders to Reach Out | Press release | -0.37% | -2.01% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Replimune Group, Inc. (REPL) And Encourages Stockholders to Reach Out | Press release | -1.35% | +0.51% |
Keep exploring
More REPL: earnings → · SEC filings → · REPL overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) | 1,452 | +0.01% | 51% |
| GENMARK DIAGNOSTICS (GNMK) | 1,451 | +0.06% | 51% |
| Altimmune, Inc. (ALT) | 1,424 | 0.00% | 48% |
| PerkinElmer, Inc. (PKI) | 1,409 | +0.11% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.